Cancer researchers at Children’s Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine, employing the same approach used to elicit an immune response against cancer cells to stimulate an immune response against the virus. Using this strategy, the researchers believe a resulting vaccine would provide protection across the human population and drive a long-term immune response.
- Study shows myocarditis linked to COVID-19 not as common as believed
- Water fleas on ‘happy pills’ have more offspring
- Breakthrough quantum-dot transistors create a flexible alternative to conventional electronics
- Losing ground in biodiversity hotspots worldwide
- Positive outlook predicts less memory decline